John Lambrick
Consejero General en RMIT University .
Perfil
John Lambrick is currently working as the General Counsel at RMIT University.
Previously, he worked as a Non-Executive Director at vivoPharm Pty Ltd.
and as a Partner at Molomby & Molomby.
He completed his graduate degree from the University of Melbourne and his undergraduate degree from Monash University.
Cargos activos de John Lambrick
| Empresas | Cargo | Inicio |
|---|---|---|
| RMIT University | Consejero General | - |
Antiguos cargos conocidos de John Lambrick.
| Empresas | Cargo | Fin |
|---|---|---|
| Molomby & Molomby | Corporate Officer/Principal | - |
vivoPharm Pty Ltd.
 vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Director/Miembro de la Junta | - |
Formación de John Lambrick.
| Monash University | Undergraduate Degree |
| University of Melbourne | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Health Technology |
| Molomby & Molomby |
- Bolsa de valores
- Insiders
- John Lambrick
